Continue To Site >
Quicklinks
  • Ask Whole Foods Mag
  • Magazine Subscription
  • View Back Issues
  • Advertise
  • Education Center
  • Ashwagandha / Shatavari Experience
  • Naturally Informed
  • Move Nutrition
  • India-America Boardroom Series
Free Newsletter Subscription
Ask WholeFoods Mag
  • News
    • All News
    • In Case You Missed It
    • Breaking News
    • Grocery News
    • Dietary Supplements News
    • Supplier News
    • Health & Beauty Aid News
    • Green News
    • Research
  • Features
    • Supplements
    • Grocery
    • Health & Beauty Aids
    • Suppliers
  • Columns
    • Debates
    • Editorial
    • Good Health Reads
    • Happy Customer
    • Herb of the Month
    • Leadership Profiles
    • Legal Tips
    • Mentors
    • Merchandising Insights
    • Recipes
    • Naturally Informed Education
    • The Nutrition Mythbuster
    • Trade Secrets
    • Vitamin Connection
    • What's Selling
    • WholeFoods Blogs
  • Products
    • Dietary Supplements
    • Grocery Products
    • Gourmet Products
    • Health & Beauty Aid Products
    • New Product Reviews
      • 2021 Archives
      • 2019 Archives
      • 2018 Archives
    • Suppliers
  • Multimedia
    • Videos
    • Podcast
    • The Natural View
  • Directory
Ask WholeFoods Mag
  • Log In
  • Register
  • Log Out
  • My Account
Free Newsletter Subscription
Quicklinks
  • Ask Whole Foods Mag
  • Magazine Subscription
  • View Back Issues
  • Advertise
  • Education Center
  • Ashwagandha / Shatavari Experience
  • Naturally Informed
  • Move Nutrition
  • India-America Boardroom Series
Home » SPONSORED BY

The Nutraceutical Market & Novel Advanced Delivery Systems

October 4, 2022
George Kokkinis and WholeFoods Magazine Contributor
In 2021, the global nutraceuticals market size was valued at USD 454.55 billion with an expected compound annual growth rate of 9.0% from 2021 to 20301 (Grandview Research). More retailers will invariably enter the market as demand for nutraceuticals grows and, to remain competitive, they must provide high-quality products that are effective for the stated purpose.

Nutraceuticals MarketHowever, the efficacy of nutraceuticals is a function of absorption and bioavailability after ingestion. Absorption refers to the process of a molecule’s movement from ingestion to its entry into systemic circulation. Bioavailability refers to the amount of the molecule that was absorbed and reached systemic circulation relative to what was ingested.

As consumers and brands begin to recognise the importance of bioavailability, a working knowledge of the mechanisms and interactions that affect nutraceutical bioavailability is imperative for determining the best approach for development of novel and innovative advanced delivery systems.

Novel Advanced Delivery Systems

Nutraceutical ingredients such as quercetin, curcumin, resveratrol, and vitamin D3 all have demonstrable beneficial effects on health but, due to their lipophilicity, they are poorly soluble in the aqueous environment of the gastrointestinal tract. Therefore, an effective delivery system is required to enhance their absorption and subsequent efficacy.

There is no-one-size-fits-all solution, and the right delivery system must be carefully selected based on various factors including the active ingredient, the final dosage format (i.e., tablet, capsule, powder, liquid spray, effervescent, etc), and the end user.

Here come liposomes

Liposomes are tiny, spherical, engineered, nanostructures that are mainly made up of a lipid bi-layer membrane around an aqueous core. They are mainly made up of biological materials, so they are seen by the body as inert. Both hydrophilic and lipophilic active ingredients can be incorporated into the liposome to achieve targeted delivery of your desired active to the cells that need it.

Liposomes rely on electrostatic charge, between the lipid molecules, to keep the membrane in place. They also rely on the subsequent electric potential at the interface of the lipid bi-layer and the liquid carrier (in our case, water).

As liposomes are generally below the visible wavelength of light (380 to 700 nm2) it is not possible to see them using a standard light microscope. So, how do you confirm that you have actually made liposomes and not a "soup" of ingredients?

Other than particle size and distribution, two important tools around the characterisation and presence of liposomes are zeta potential and transmission electron microscopy imaging.

Zeta potential

Zeta potential is the electric potential at the interface of the lipid bi-layer and the water surrounding it.

Colloidal dispersions (eg, liposomes in water) with a medium to high zeta potential (negative or positive charge greater than 20 eV) are electrically stable while those with a low zeta potential (anything below 20 eV) are unstable and tend to coagulate or flocculate (clump).

Also, zeta potential is one of the available tools to characterise a double layer, such as that in a liposome. The below chart shows the difference between a particular formulation made by two different manufacturers using different methods of manufacture.

Zeta Potential

Pharmako Biotechnologies Competitor Liposomal D3 
Competitor Liposomal D3
PlexoZome® D3 – high zeta – low zeta potential means 
Potential means more less stability and high coagulation. stability and no coagulation. 

TEM (Transmission Electron Microscopy) imaging

TEM is an imaging technique that uses an electron beam to image a nanoparticle sample. It provides much higher resolution than is possible with light-based imaging techniques.

TEM is an important method for the characterisation of the presence, size and shape of liposomes. It can directly visualise single particles (at the low end nano scale) and even go into detail of their inner structure, eg lipid bi-layer. There are two distinct methods for TEM visualisation. One is cryo-electron microscopy (cryo-TEM) and the other is negative staining TEM.

Liposomes need to be preserved for the electron microscope to best visualize them close to their native structure. As such, cryo-TEM is best suited for this application. Cryo-TEM uses thin films of suspensions that are plunge frozen to create vitrified ice films that can be imaged directly in the electron microscope under liquid nitrogen temperature. This requires very expensive equipment, detailed methods, and experienced operators, hence it is not commercially readily available.

The other method is negative staining TEM (usually with uranyl acetate). As liposomes do not have enough contrast they need to be stained in order to distinguish their features. Negative staining TEM is faster and simpler than cryo-TEM. It also requires less advanced equipment, methods and is more readily available.

Negative Staining TEM
Picture 1. Negative staining TEM of competitor D3 with 2% uranyl acetate. Liposomes are not clearly visible and, whatever structures are there, appear to be clumping, due to their very low zeta potential.


Negative Staining TEM
Picture 2. Negative staining TEM of Pharmako Biotechnologies PlexoZome® D3 with 2% uranyl acetate. Liposomes are clearly visible and are freely distributed in the liquid medium.


Cryo TEM
Picture 3. Cryo-TEM of Pharmako Biotechnologies PlexoZome® D3. Liposomal multilamellar membrane is clearly seen.

Education opportunity

Formulation opportunities and new ingredients were discussed in depth at the Naturally Informed virtual event Stress and Mental Wellness: Mastering the Market on September 20-22, 2022. A session presented by Gencor titled Mental Wellness for the Seven Living Generations covered the emerging research. Register here to view on demand.

*Content provided by Gencor.
    Education Center
    KEYWORDS Delivery Systems liposomes nutraceuticals
    • Related Articles

      Delivery Systems Head into the Future

      The Future of Supply Chain & Delivery Systems

      Delivery System: Oral Films Expanding to Nutraceutical Market

    George kokkins
    People news microphone orange and blue laptop icon

    Experts in the natural products industry share their insights on top trending topics, research, and industry news and events.

    *These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

    Recommended For You
    Latest Publication
    Screenshot_2026-05-26_at_7.47.16_AM.jpg
    June/July 2026
    CovHeart.jpg
    2026 Deep Dive Cardiovascular Health
    Screenshot_2026-04-16_at_11.51.39_AM.png
    May 2026
    CovMi26.jpg
    2026 Mastering the Microbiome Market
    Most Popular
    • GettyImages-2260827018.jpg

      Karnataka High Court Issues Interim Stay on Ashwagandha Leaf Ban

      By Richard Ortega, Associate Editor, WholeFoods Magazine
      May 20, 2026
    • Anaheim Convention Center hosted four days of innovation, education, networking, and trendspotting at Expo West 2026.

      Expo West 2026 Trend Report: Innovation, Transparency & Functional Wellness

      By WholeFoods Magazine Staff
      May 26, 2026
    • Fostering mental wellness.

      The Pillars of Mental Resilience

      By Jennifer Joseph
      June 1, 2026

    WholeFoods Magazine is your one-stop resource for health and nutrition articles. We provide important information regarding industry news, research, and trends.

    The Magazine

    • Current Issue
    • Subscribe
    • Renew
    • Change of Address

    Information

    • Source Directory
    • Helpful Resources
    • Job Finder

    About Us

    • About Us
    • Contact Us
    • Advertise

    Social

    NOTE: WholeFoods Magazine is a business-to-business publication. Information on this site should not be considered medical advice or a way to diagnose or treat any disease or illness. Always seek the advice of a medical professional before making lifestyle changes, including taking a dietary supplement. The opinions expressed by contributors and experts quoted in articles are not necessarily those of the publisher or editors of WholeFoods.

    © Copyright 2026 WFC, Inc. All Rights Reserved.
    Privacy PolicyTerms